SSKN 2x potential at leastProbably moving into range high again. 83% revenue growth perspective, undervalued compared to competitors. Not a bad play. In spot.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.30EUR
−9.81 MEUR
30.22 MEUR
18.32 M
About Strata Skin Sciences, Inc.
Sector
Industry
CEO
Dolev Rafaeli
Website
Headquarters
Horsham
Employees (FY)
99
Founded
1989
STRATA Skin Sciences, Inc. is a medical technology company in Dermatology and Plastic Surgery. It engages in developing, commercializing and marketing products for the treatment of dermatologic conditions. The firm operates through the following segments: Dermatology Recurring Procedures and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. The Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. The company was founded by Dina Gutkowicz-Krusin in December 1989 and is headquartered in Horsham, PA.
SSKN - Downward channel breakout long from $2.23 to $6.43SSKN was running within a long term downward channel and now seems breaking out. It has lots of insider buying and strong twiggs money flow index. We think it has good upside potential.
* Trade Criteria *
Date First Found- August 7, 2018
Pattern/Why- Long term upward channel
Entry Criteria- $2
momentum indicatorshows that price will bounce back to high of new trend or higher.
50/ 200 DMA golden cross on hourly indicates new short term trend near or has started.
Inverse Head and Shoulders ON WATCHWithin symmetrical Triangle & MACD showing + divergence! Measuring rule implies ≈40% increase w/ decisive breakout. Initial PT 1.5, 2nd 1.9.
MACD also broke out of downtrend from April17, and Momentum moving positive on multiple time frames.
Revenue, Net Income and EPS increasing on annual basis.
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of E2OM is 0.36 EUR — it hasn't changed in the past 24 hours. Watch STRATA SKIN SCIENCES INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange STRATA SKIN SCIENCES INC stocks are traded under the ticker E2OM.
E2OM stock has fallen by 2.72% compared to the previous week, the month change is a 4.07% rise, over the last year STRATA SKIN SCIENCES INC has showed a 4.07% increase.
We've gathered analysts' opinions on STRATA SKIN SCIENCES INC future price: according to them, E2OM price has a max estimate of 2.41 EUR and a min estimate of 1.85 EUR. Watch E2OM chart and read a more detailed STRATA SKIN SCIENCES INC stock forecast: see what analysts think of STRATA SKIN SCIENCES INC and suggest that you do with its stocks.
E2OM reached its all-time high on May 16, 2024 with the price of 0.37 EUR, and its all-time low was 0.34 EUR and was reached on May 13, 2024. View more price dynamics on E2OM chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
E2OM stock is 0% volatile and has beta coefficient of 0.58. Track STRATA SKIN SCIENCES INC stock price on the chart and check out the list of the most volatile stocks — is STRATA SKIN SCIENCES INC there?
Today STRATA SKIN SCIENCES INC has the market capitalization of 12.34 M, it has decreased by 10.29% over the last week.
Yes, you can track STRATA SKIN SCIENCES INC financials in yearly and quarterly reports right on TradingView.
STRATA SKIN SCIENCES INC is going to release the next earnings report on Aug 13, 2024. Keep track of upcoming events with our Earnings Calendar.
E2OM earnings for the last quarter are −0.04 EUR per share, whereas the estimation was −0.06 EUR resulting in a 33.61% surprise. The estimated earnings for the next quarter are −0.06 EUR per share. See more details about STRATA SKIN SCIENCES INC earnings.
STRATA SKIN SCIENCES INC revenue for the last quarter amounts to 6.26 M EUR despite the estimated figure of 6.41 M EUR. In the next quarter revenue is expected to reach 6.86 M EUR.
E2OM net income for the last quarter is −3.12 M EUR, while the quarter before that showed −3.44 M EUR of net income which accounts for 9.19% change. Track more STRATA SKIN SCIENCES INC financial stats to get the full picture.
No, E2OM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 23, 2024, the company has 99.00 employees. See our rating of the largest employees — is STRATA SKIN SCIENCES INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. STRATA SKIN SCIENCES INC EBITDA is −802.59 K EUR, and current EBITDA margin is −1.25%. See more stats in STRATA SKIN SCIENCES INC financial statements.
Like other stocks, E2OM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade STRATA SKIN SCIENCES INC stock right from TradingView charts — choose your broker and connect to your account.